Characteristics of children who have full or incomplete fetal alcohol syndrome

Valborg L Kvigne1, Gary R Leonardson, Martha Neff-Smith

  • 1Aberdeen Area Indian Health Service, PHS Indian Hospital, Rapid city, South Dakota, USA.

The Journal of Pediatrics
|November 3, 2004
PubMed

Insights

American Indian children with full or incomplete fetal alcohol syndrome (FAS) experience significant health issues and higher hospitalization rates. Early identification and tailored services are crucial for addressing their complex needs.

Area of Science:

  • Pediatrics
  • Public Health
  • Genetics

Background:

  • Fetal alcohol syndrome (FAS) is a leading preventable cause of birth defects and intellectual disability.
  • American Indian populations may face unique challenges and higher prevalence rates of FAS.
  • Understanding the specific clinical features and healthcare needs of this demographic is essential.

Purpose of the Study:

  • To delineate the clinical characteristics of American Indian children diagnosed with full or incomplete fetal alcohol syndrome (FAS).
  • To compare hospitalization rates and reasons for admission among children with full FAS, incomplete FAS, and controls.
  • To identify the health, learning, and social service requirements for affected children.

Main Methods:

  • Retrospective case-control studies involving Northern Plains American Indian children diagnosed between 1981 and 1993.
  • Utilized ICD-9-CM code 760.71 for case identification.
  • Compared children with full FAS (n=43) and incomplete FAS (n=35) against a control group.

Main Results:

  • Children with FAS and incomplete FAS exhibited increased facial dysmorphology, growth deficits, CNS dysfunction, and muscular issues compared to controls.
  • Higher hospitalization rates were observed in FAS cases for otitis media, pneumonia, dehydration, and anemia.
  • FAS cases experienced longer hospital stays and were more frequently placed in foster care.

Conclusions:

  • Full and incomplete FAS present substantial health, developmental, and social challenges for American Indian children.
  • Healthcare providers and community programs must proactively identify and address the multifaceted needs of these children.
  • Optimized services are critical for improving outcomes and supporting affected individuals and families.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...